Saturday 17 October 2026
Export ARAY’s income statement to Excel — free account
Accuray Incorporated
ARAY Healthcare Medical Devices
Accuray Incorporated’s revenue for fiscal 2026 (year ended June 2026) was $401.9 million, down 12.3% from fiscal 2025. In the quarter to June 2026, revenue fell 20.9%, EPS fell 300.0%, free cash flow grew 117.8% and total debt rose 18.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.16
0.01
−5.88%
Follow ARAY
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (80.08%) | (101.06%) | (70.32%) | (36.07%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
1 | 2 | 3 | 4 | |
| (10.77%) | (9.90%) | (7.69%) | (4.15%) | ||
ROIC |
(11.25%) | (12.63%) | (8.07%) | (0.66%) | |
Return on Tangible Assets |
(39.77%) | (39.64%) | (29.15%) | (14.00%) | |
Average Days of Receivables |
61.21 | 54.99 | 50.92 | 44.02 | |
Free Cash Flow per Share |
(0.10) | (0.21) | (0.02) | 0.15 | |
Free Cash Flow |
(12.84) | (25.84) | (2.66) | 17.28 | |
Capital Expenditures |
(5.86) | (6.72) | (7.21) | (5.06) | |
| Other line items | |||||
Cash ROIC |
(5.60%) | (12.06%) | (1.21%) | 6.83% | |
Accounts Receivable Turnover |
5.34 | 6.00 | 5.90 | 6.17 | |
Accounts Payable Turnover |
7.79 | 6.33 | 6.48 | 6.76 | |
Inventory Turnover |
2.02 | 2.07 | 2.11 | 2.01 | |
Average Days of Payables |
50.96 | 61.44 | 50.31 | 49.63 | |
Days of Inventory on Hand |
184.80 | 182.25 | 174.51 | 182.00 | |
Tax Rate |
0.04 | 0.06 | 0.07 | 0.15 | |
Research and Development Expense of Revenue |
9.39% | 9.72% | 10.12% | 10.47% | |
Selling, General and Administrative Expense of Revenue |
20.89% | 20.61% | 20.26% | 20.66% | |
Share Based Compensation of Revenue |
1.61% | 1.77% | 2.05% | 2.30% | |
Interest Coverage |
(0.80) | (0.98) | (0.77) | (0.07) | |
Operating CF/Net income |
0.14 | 0.41 | (0.13) | (1.16) | |
Depreciation/Fixed assets |
0.59 | 0.48 | 0.39 | 0.33 | |
Capex/Depreciation |
(0.37) | (0.48) | (0.63) | (0.53) | |
Revenue per Share |
3.28 | 3.45 | 3.61 | 3.79 | |
Operating CF per Share |
(0.06) | (0.15) | 0.04 | 0.19 | |
Capex per Share |
(0.05) | (0.05) | (0.06) | (0.04) | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.01 |
Columns are period end dates